{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:36:01Z","timestamp":1773455761080,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2003,5,1]]},"DOI":"10.1038\/sj.leu.2402899","type":"journal-article","created":{"date-parts":[[2003,5,15]],"date-time":"2003-05-15T17:50:08Z","timestamp":1053021008000},"page":"925-930","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Infectious complications in patients with acute promyelocytic leukaemia treated with the AIDA regimen"],"prefix":"10.1038","volume":"17","author":[{"given":"C","family":"Girmenia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Lo Coco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Breccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Latagliata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Spadea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"D'Andrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Micozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Alimena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Mandelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,5,15]]},"reference":[{"key":"BF2402899_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0037-1963(01)90002-2","volume":"38","author":"P Fenaux","year":"2001","unstructured":"Fenaux P, Chomienne C, Degos L . All trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol 2001; 38: 13\u201325.","journal-title":"Semin Hematol"},{"key":"BF2402899_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1200\/JCO.1998.16.1.78","volume":"16","author":"N Asou","year":"1998","unstructured":"Asou N, Adachi J, Tamura J, Kanamaru A, Kageyama S, Hiraoka A et al. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. J Clin Oncol 1998; 16: 78\u201385.","journal-title":"J Clin Oncol"},{"key":"BF2402899_CR3","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1182\/blood.V93.12.4131","volume":"93","author":"AK Burnett","year":"1999","unstructured":"Burnett AK, Grimwade D, Solomon E, Wheatley K, Goldstone AH . Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the randomized MRC trial. Blood 1999; 93: 4131\u20134143.","journal-title":"Blood"},{"key":"BF2402899_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1200\/JCO.1997.15.2.483","volume":"15","author":"E Estey","year":"1997","unstructured":"Estey E, Thall PF, Pierce S, Kantajian H, Keating M . Treament of newly diagnosed acute promyelocytic leukemia without cytarabine. J Clin Oncol 1997; 15: 483\u2013490.","journal-title":"J Clin Oncol"},{"key":"BF2402899_CR5","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood.V94.4.1192","volume":"94","author":"P Fenaux","year":"1999","unstructured":"Fenaux P, Chastang C, Chevret S, Sanz MA, Dompret H, Archimbaud E et al. A randomized comparison of all-trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy, and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood 1999; 94: 1192\u20131200.","journal-title":"Blood"},{"key":"BF2402899_CR6","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/sj.leu.2401843","volume":"14","author":"E Lengfelder","year":"2000","unstructured":"Lengfelder E, Reichert A, Schoch C, Haase D, Haferlach T, Loffler H et al. Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. Leukemia 2000; 14: 1362\u20131370.","journal-title":"Leukemia"},{"key":"BF2402899_CR7","first-page":"1014","volume":"90","author":"F Mandelli","year":"1997","unstructured":"Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C et al. Molecular remission in PML\/RAR\u03b1-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood 1997; 90: 1014\u20131021.","journal-title":"Blood"},{"key":"BF2402899_CR8","first-page":"3015","volume":"94","author":"MA Sanz","year":"1999","unstructured":"Sanz MA, Mart\u00edn G, Ray\u00f3n C, Esteve J, Gonzalez M, Diaz-Mediavilla J et al. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML\/RARa-positive acute promyelocytic leukemia. Blood 1999; 94: 3015\u20133021.","journal-title":"Blood"},{"key":"BF2402899_CR9","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJM199710093371501","volume":"337","author":"MS Tallman","year":"1997","unstructured":"Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A et al. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997; 337: 1021\u20131028.","journal-title":"N Engl J Med"},{"key":"BF2402899_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1046\/j.1365-2141.1999.01501.x","volume":"106","author":"D Grimwade","year":"1999","unstructured":"Grimwade D . The pathogenesis of acute promyelocytic leukemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease. Br J Haematol 1999; 106: 591\u2013613.","journal-title":"Br J Haematol"},{"key":"BF2402899_CR11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1182\/blood.V94.1.12.413a44_12_22","volume":"94","author":"F Lo Coco","year":"1999","unstructured":"Lo Coco F, Diverio D, Falini B, Biondi A, Nervi C, Pelicci PG . Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia. Blood 1999; 94: 12\u201322.","journal-title":"Blood"},{"key":"BF2402899_CR12","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1182\/blood.V94.7.2230.419k05_2230_2235","volume":"94","author":"EH Estey","year":"1999","unstructured":"Estey EH, Giles FJ, Kantarjian H, O'Brien S, Cortes J, Freireich EJ, Lopez-Berestein G, Keating M . Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Blood 1999; 94: 2230\u20132235.","journal-title":"Blood"},{"key":"BF2402899_CR13","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/0140-6736(92)92625-P","volume":"340","author":"F Lo Coco","year":"1992","unstructured":"Lo Coco F, Diverio D, Pandolfi PP, Biondi A, Rossi V, Avvisati G et al. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. Lancet 1992; 340: 1437\u20131438.","journal-title":"Lancet"},{"key":"BF2402899_CR14","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/sj.leu.2401375","volume":"13","author":"C Girmenia","year":"1999","unstructured":"Girmenia C, Latagliata R, Tosti S, Morano SG, Celesti F, Coppola L et al. Outpatient management of acute promyelocytic leukemia after consolidation chemotherapy. Leukemia 1999; 13: 514\u2013517.","journal-title":"Leukemia"},{"key":"BF2402899_CR15","first-page":"814","volume":"84","author":"C Girmenia","year":"1999","unstructured":"Girmenia C, Alimena G, Latagliata R, Morano SG, Celesti F, Coppola L et al. Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit. Haematologica 1999; 84: 814\u2013819.","journal-title":"Haematologica"},{"issue":"Suppl. 1","key":"BF2402899_CR16","first-page":"235a","volume":"90","author":"S Keating","year":"1997","unstructured":"Keating S, Suciu S, Mandelli F, De Witte T, Willemze R, Archimbaud E et al. Autologous BMT or PSCT for patients with AML in first CR: a preliminary analysis of the AML 10 study of the leukemia cooperative group (LCG) of the EORTC and GIMEMA. Blood 1997; 90 (Suppl. 1): 235a.","journal-title":"Blood"},{"key":"BF2402899_CR17","unstructured":"Archimbaud E, Jehn U, Thomas X, De Cataldo F, Fillet G, Belhabri A et al. Idarubicin vs mitoxantrone in association with VP-16 and Ara-c for induction\/consolidation therapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemia (AML). Final analysis of a randomized trial. Proceedings of the 33rd ASCO Annual Meeting 1997; 16: 3a (Abstract 7)."},{"key":"BF2402899_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.7326\/0003-4819-117-4-292","volume":"117","author":"SR Frankel","year":"1992","unstructured":"Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell Jr RO . The \u2018retinoic acid syndrome\u2019 in acute promyelocytic leukemia. Ann Intern Med 1992; 117: 292\u2013296.","journal-title":"Ann Intern Med"},{"key":"BF2402899_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/sj.leu.2402807","volume":"17","author":"S de Button","year":"2003","unstructured":"de Button S, Chevret S, Coiteux V, Dombret, H, Sanz M, San Miguel J et al. Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukaemia (APL) with low white blood cell counts: results from APL 93 trial. Leukemia 2003; 17: 339\u2013342.","journal-title":"Leukemia"},{"key":"BF2402899_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/clinids\/18.1.25","volume":"18","author":"PY Bochud","year":"1994","unstructured":"Bochud PY, Egglman P, Calandra T, Van Melle G, Saghafi G, Francioli P . Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis 1994; 18: 25\u201331.","journal-title":"Clin Infect Dis"},{"key":"BF2402899_CR21","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(95)90117-5","volume":"345","author":"P Richard","year":"1995","unstructured":"Richard P, Del Valle GA, Moreau P, Milpied N, Felice MP, Daeschler T et al. Viridans streptococcal bacteraemia in patients with neutropenia. Lancet 1995; 345: 1607\u20131609.","journal-title":"Lancet"},{"key":"BF2402899_CR22","first-page":"415","volume":"7","author":"D Valteau","year":"1991","unstructured":"Valteau D, Hartmann O, Brugieres L, Vassal G, Benhamou E, Andremont A et al. Streptococcal septicaemia following autologous bone marrow transplantation in children treated with high-dose chemotherapy. Bone Marrow Transplant 1991; 7: 415\u2013419.","journal-title":"Bone Marrow Transplant"},{"key":"BF2402899_CR23","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/S0140-6736(83)90799-7","volume":"ii","author":"J Cohen","year":"1983","unstructured":"Cohen J, Donnelly JP, Worsley AM, Catovsky D, Goldman JM, Galton DAG . Septicemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet 1983; ii: 1452\u20131454.","journal-title":"Lancet"},{"key":"BF2402899_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/0002-9343(90)90373-L","volume":"89","author":"DC Classen","year":"1990","unstructured":"Classen DC, Burke JP, Ford CD, Evershed S, Aloia MR, Wilfahrt JK et al. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis. Am J Med 1990; 89: 441\u2013446.","journal-title":"Am J Med"},{"key":"BF2402899_CR25","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/clinids\/14.6.1201","volume":"14","author":"LS Elting","year":"1994","unstructured":"Elting LS, Bodey GP, Keefe BH . Septicemia and shock syndrome due to viridans streptococci: a case\u2013control study of predisposing factors. Clin Infect Dis 1994; 14: 1201\u20131207.","journal-title":"Clin Infect Dis"},{"key":"BF2402899_CR26","first-page":"1247","volume":"96","author":"MA Sanz","year":"2000","unstructured":"Sanz MA, Lo Coco F, Martin G, Avvisati G, Rayon C, Barbui T et al. Definition of relapse risk and role of non-anthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood 2000; 96: 1247\u20131253.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402899.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402899","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402899.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:17:11Z","timestamp":1648761431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,1]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5,1]]}},"alternative-id":["BF2402899"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402899","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,1]]},"assertion":[{"value":"22 October 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}